Overview

Companies

Metrics

Content

Purchase

The following is a list of metrics included in A Guidebook to Pharma Brand Optimization: Lifecycle Management Strategy.  While this list is not inclusive of all the data in the report, it summarizes the main categories and types of data included in each chapter.

Chapter 1:

• Companies’ LCM Structures
• Dedicated Lifecycle Management Team
• Dedicated Lifecycle Management Team Reports to Which Department
• Departments Responsible for LCM when No Dedicated Team Exists
• Company F’s LCM Structure
• Title of Those Responsible for Spearheading LCM
• Other Functions Involved in LCM During Various Time Periods
• LCM Budgets Tied to Individual Brands
• Funding of LCM Budgets
• Lifecycle Management Ratings
• Important Factors to Have a Successful LCM Effort
• Areas with Greatest Room for Improvement
• Importance of Criteria in Assessing LCM Tactics
• LCM Success Measurements

Chapter 2:

• Pre-Launch LCM Tactical Timeline
• Pre-Launch LCM Strategy Investment Levels
• Average Time to Implement Pre-Launch LCM Strategies
• Pre-Launch LCM Strategy Time to Implement vs. Return on Investment
• Pre-Launch LCM Strategy Return on Investment

There are five LCM tactics examined in this chapter, including divestitures, new
formulations/delivery systems, strategic alliances/licensing, publications strategy and contracting with large volume purchasers.  Within each LCM tactic profile there are the following graphics:

• Tactic Dashboard: Implementation Timeline, Return on Investment, Development Time, Average Investment, Industry Case Studies
• Planning for Tactic Begins
• Implementation for Tactic Begins
• Effectiveness of LCM Tactic
  

Chapter 3:

• Peak (Launch until two years prior to US patent expiration) LCM Tactical Timeline
• Peak LCM Strategy Investment Levels
• Average Time to Implement Peak LCM Strategies
• Peak LCM Strategy Time to Implement vs. Return on Investment
• Peak LCM Strategy Return on Investment

There are six LCM tactics examined in this chapter: strategic pricing, new
dosing frequency, new dosing strength, new indication, CRM/disease management,
market repositioning and repurposing.  Within each LCM tactic profile there are the
following graphics:

• Tactic Dashboard: Implementation Timeline, Return on Investment, Development Time, Average Investment, Industry Case Studies
• Planning for Tactic Begins
• Implementation for Tactic Begins
• Effectiveness of LCM Tactic

Chapter 4:

• Mature (Two years prior to US patent expiration and beyond) LCM Tactical Timeline
• Mature LCM Strategy Investment Levels
• Average Time to Implement Mature LCM Strategies
• Mature LCM Strategy Time to Implement vs. Return on Investment
• Mature LCM Strategy Return on Investment

There are six LCM tactics examined in this chapter including: pediatric indications, new combinations, next generation product, patent litigation, branded generics, Rx-to-OTC and removal from market.  Within each LCM tactic profile there are the following graphics:

• Tactic Dashboard: Implementation Timeline, Return on Investment, Development Time, Average Investment, Industry Case Studies
• Planning for Tactic Begins
• Implementation for Tactic Begins
• Effectiveness of LCM Tactic

Chapter 5:
There are seven individual brand LCM profiles, most of which contain the following metrics and graphics.

• Brand Overview: Peak Sales, Therapeutic Area, Company Size, Brand Erosion, Number of Years of Patent Protection on US Market
• Competitive Outlook: Number of Generic and Branded Competitors
• Greatest Threats to Brand
• LCM Tactical Approach
• LCM Tactic Timelines: When Planning for Tactic Begins
• Annual LCM Strategy Investments
• LCM Strategy Annual Investments by Time Period
• LCM Headcount Support
• Percentage of Brand’s Marketing Budget Allocated to LCM
• LCM Strategy Investments, Returns and Returns on Investment Percentages
• LCM Strategies’ Average Returns Per Dollar Invested